Tel Aviv – A study conducted Israel call pregnant women that vaccinated against COVID-19 can provide protection to their babies. According to research conducted last February, antibodies were detected in 20 pregnant women who were given both doses the Pfizer-BioNTech vaccine during the third trimester of pregnancy and in newborns, via transfer of the placenta.
“Our findings highlight that vaccinating pregnant women can provide protection for mothers and babies from SARS-CoV-2 infection,” the study said as quoted by the report. Reuters, Wednesday (17/3/2021).
The findings were made by researchers from Hadassah – University Medical Center in Jerusalem published this month on medRxiv – an online distribution service for research manuscripts that were not published because they had not been peer reviewed – and reported by Israeli media on Tuesday.
The researchers state that the study is small and call for further research to be carried out to measure the impact vaccination at various gestational ages, with the safety and efficacy of the various vaccines currently available.
Quoted from Jerusalem Post, one of the researchers, Dana Wolf, said the group will now begin to look at how long the antibodies triggered by the vaccination will last in babies.
Last month, Pfizer and BioNTech said they had started an international study of 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women.
The trial will also assess whether vaccinated pregnant women transfer protective antibodies to their babies.
A separate study in the United States, published last week and awaiting review, found that antibodies induced in pregnant women from the COVID-19 mRNA vaccine, such as the Pfizer-BioNTech and Moderna strains, are transferred to the baby via the placenta or breast milk.
(izt / nvc)
– .
